Ledger.Open graph →
SEC Form D · Amendment · filed March 5, 2026

MindImmune Therapeutics, Inc

Offering
$17.0M
Sold
$15.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
KINGSTON, RI
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Bruce Lyman · McLean, VADirectorBarry Oates · Springville, UTExec · DirectorChristopher Buntel · Springville, UTDirectorDennis Decker · Springville, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗